CD8A and neoplasm: Programmed death‐ligand 1 (PD‐L1), one of the most frequently upregulated checkpoint proteins in tumor, can bind to programmed death receptor 1 (PD‐1) on CD8+ T cells, which leads to the inhibition of the survival and effector functions of CD8+ T cells.223